News

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...
In recent months, several cruise ships have experienced significant outbreaks of the norovirus. This highly infectious and ...
In recent months, several cruise ships have experienced significant outbreaks of the norovirus. This highly infectious and ...